Annual Cash & Cash Equivalents
$79.93 M
-$63.31 M-44.20%
31 December 2023
Summary:
Terns Pharmaceuticals annual cash & cash equivalents is currently $79.93 million, with the most recent change of -$63.31 million (-44.20%) on 31 December 2023. During the last 3 years, it has risen by +$5.07 million (+6.78%). TERN annual cash & cash equivalents is now -44.20% below its all-time high of $143.24 million, reached on 31 December 2022.TERN Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$270.14 M
+$178.64 M+195.24%
30 September 2024
Summary:
Terns Pharmaceuticals quarterly cash and cash equivalents is currently $270.14 million, with the most recent change of +$178.64 million (+195.24%) on 30 September 2024. Over the past year, it has increased by +$232.24 million (+612.89%). TERN quarterly cash and cash equivalents is now at all-time high.TERN Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TERN Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -44.2% | +612.9% |
| 3 y3 years | +6.8% | +317.2% |
| 5 y5 years | -3.1% | - |
TERN Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -44.2% | +67.6% | at high | +1507.4% |
| 5 y | 5 years | -44.2% | +548.4% | at high | +2091.4% |
| alltime | all time | -44.2% | +548.4% | at high | +2091.4% |
Terns Pharmaceuticals Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $270.14 M(+195.2%) |
| June 2024 | - | $91.50 M(+40.5%) |
| Mar 2024 | - | $65.10 M(-18.6%) |
| Dec 2023 | $79.93 M(-44.2%) | $79.93 M(+110.9%) |
| Sept 2023 | - | $37.89 M(-53.2%) |
| June 2023 | - | $80.92 M(-56.1%) |
| Mar 2023 | - | $184.35 M(+28.7%) |
| Dec 2022 | $143.24 M | $143.24 M(+127.4%) |
| Sept 2022 | - | $62.98 M(+274.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2022 | - | $16.81 M(-61.7%) |
| Mar 2022 | - | $43.88 M(-8.0%) |
| Dec 2021 | $47.70 M(-36.3%) | $47.70 M(-26.3%) |
| Sept 2021 | - | $64.75 M(-4.2%) |
| June 2021 | - | $67.59 M(-31.6%) |
| Mar 2021 | - | $98.83 M(+32.0%) |
| Dec 2020 | $74.85 M(+507.2%) | $74.85 M(+444.2%) |
| Sept 2020 | - | $13.76 M(+11.6%) |
| Dec 2019 | $12.33 M(-85.1%) | $12.33 M |
| Dec 2018 | $82.52 M | - |
FAQ
- What is Terns Pharmaceuticals annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Terns Pharmaceuticals?
- What is Terns Pharmaceuticals annual cash & cash equivalents year-on-year change?
- What is Terns Pharmaceuticals quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Terns Pharmaceuticals?
- What is Terns Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
What is Terns Pharmaceuticals annual cash & cash equivalents?
The current annual cash & cash equivalents of TERN is $79.93 M
What is the all time high annual cash & cash equivalents for Terns Pharmaceuticals?
Terns Pharmaceuticals all-time high annual cash & cash equivalents is $143.24 M
What is Terns Pharmaceuticals annual cash & cash equivalents year-on-year change?
Over the past year, TERN annual cash & cash equivalents has changed by -$63.31 M (-44.20%)
What is Terns Pharmaceuticals quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of TERN is $270.14 M
What is the all time high quarterly cash and cash equivalents for Terns Pharmaceuticals?
Terns Pharmaceuticals all-time high quarterly cash and cash equivalents is $270.14 M
What is Terns Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
Over the past year, TERN quarterly cash and cash equivalents has changed by +$232.24 M (+612.89%)